Silvio Garattini

is the director of the Mario Negri Institute of Pharmacological Research, which he founded in 1963. The institute has produced over 13,000 scientific papers in oncology, chemotherapy and immunology of cancer, pharmacology and neuropsychopharmacology. Garattini has authored hundreds of papers and studies on pharmacology. He has founded the European Organization for Research on Treatment of Cancer. He holds positions of prestige in Europe's leading scientific bodies: he is a member of the board of Italy's Higher Institute of Health, president of the European Society of Biochemical Pharmacology, vice-president of Italy's Higher Health Council, president of the Research and Development Committee of Italy's Drug Administration. He is also a member of the Higher Health Council and of Italy's National Bioethics Committee. His books include: Fa bene o fa male? Salute, ricerca e farmaci: tutto quello che bisogna sapere (Sperling & Kupfer, 2013).